Share on PinterestNew research shows that COVID-19 mortality risk rose with each day that officials did not implement emergency measures.Image credit: Joe Raedle/Getty Images.The imposition of physical distancing measures by state governments during the COVID-19 pandemic has been politically controversial in the United States.Critics have questioned the necessity and effectiveness of such measures, particularly in…
By Jessica Hamzelou Fertilising an egg under a microscopeMorsa Images/Getty Images Women who wait three months longer for their IVF treatment have similar outcomes to those who are treated immediately, according to a study of women who experienced routine delays. The findings are reassuring for people experiencing fertility treatment delays due to the covid-19 pandemic,…
Sloppy laboratory practices at the Centers for Disease Control and Prevention caused contamination that rendered the nation’s first coronavirus tests ineffective, federal officials confirmed on Saturday.Two of the three C.D.C. laboratories in Atlanta that created the coronavirus test kits violated their own manufacturing standards, resulting in the agency sending tests that did not work to…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.